Sichuan Xieli Phamaceutical Co., Ltd Win the Award of 2017 Most Promising Pharmaceutical Companies

    On the afternoon of June 19, the 2017 Award for Top 100 Internationalized Pharmaceutical Companies was officially released at the 8th “China and World” CEO Summit, organized by UBM EMEA and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) and co-organized by Shanghai UBM Sinoexpo International Exhibition Co.,Ltd (UBM Sinoexpo). Sichuan Xieli was awarded as 2017 Most Promising Pharmaceutical Companies.

    Meng Dongping, Vice President of CCCMHPIE, said that the international level of an industry depends on the performance of the active individual companies. Preparations are exported to the regulated market on a large scale. The amount of overseas M&A hits a record high. The pursuit of high-end international certification speeds up. The momentum of going global among Chinese pharmaceutical companies’ remains strong and more achievements continue to be made with closer relations with the world pharmaceutical market. The power of examples cannot be underestimated. The aim of the award list is to give a strong impetus to the pharmaceutical companies that have made great achievements when going global. We aim to raise the international recognition and influence of the leading companies and set a good example in the industry for internationalization.

    Awarding Ceremony  

    List of the Awarded Companies

    The selection activity started at 2016. The result of last year received well recognition among pharmaceutical companies and exerted wide-range social influence. The selection in 2017 set up 3 awards: Quality Suppliers and Partners in the World Market (Top 60), World Leading Companies for Preparations (Top 20) and the Most Potential Companies (Top 20).